ARCHIVES

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers

January 15, 1993

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

Henry Brem Named Director Of Neurology At Johns Hopkins.

July 28, 2000

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014